Call Now

Human MSR1 / SCARA1 / CD204 Protein (His Tag)

CD204,phSR1,phSR2,SCARA1,SR-A,SRA

Catalog Number P10427-H07H
Organism Species Human
Host Human Cells
Synonyms CD204,phSR1,phSR2,SCARA1,SR-A,SRA
Molecular Weight The recombinant human MSR1 consisting of 391 amino acids predicts a molecular mass of 43 kDa. Due to glycosylation, apparent molecular mass of rh MSR1 is approximately 55-65 kDa in SDS-PAGE under reducing conditions.
predicted N His
SDS-PAGE
Purity > 95 % as determined by SDS-PAGE
Protein Construction A DNA sequence encoding the extracellular domain (Lys 77-Leu 451) of human scavenger receptor 1 isoform type 1 (NP_619729.1) was fused with the polyhistidine tag at the N-terminus.
Bio-activity
Research Area Immunology |Signal Transduction |Metabolism |Types of disease |Metabolism in Heart disease
Formulation Lyophilized from sterile PBS, pH 7.5
1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background Macrophage scavenger receptor types I and II, also known as Macrophage acetylated LDL receptor I and II, Scavenger receptor class A member 1, CD204, MSR1 and SCARA1, is a single-pass type I I membrane protein which contains one collagen-like domain and one SRCR domain. Macrophages are distributed in all peripheral tissues and play a critical role in the first line of the innate immune defenses against bacterial infection by phagocytosis of bacterial pathogens through the macrophage scavenger receptor 1 (MSR1). MSR1 / SCARA1 is one of the membrane glycoproteins implicated in the pathologic deposition of cholesterol in arterial walls during atherogenesis. Two types of receptor subunits exist. These receptors mediate the endocytosis of a diverse group of macromolecules, including modified low density lipoproteins (LDL). MSR1 / SCARA1 is also involved in chronic inflammation which is a risk factor for prostate cancer. MSR1 1 gene was identified as a candidate susceptibility gene for hereditary prostate cancer and as a risk factor for sporadic prostate cancer.
Reference
  • Wang L. et al., 2003, Nat Genet. 35 (2): 128-9.
  • Chen Y.C. et al., 2008, Cancer Epidemiol Biomarkers Prev. 17 (4): 1001-3.
  • Shirato K. et al., 2009, Pflugers Arch. 459 (1): 93-103.
  • Sun J. et al., 2006, Prostate. 66 (7): 728-37.